Lyubov Zaitseva

2.2k total citations
28 papers, 1.7k citations indexed

About

Lyubov Zaitseva is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Lyubov Zaitseva has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Hematology and 9 papers in Genetics. Recurrent topics in Lyubov Zaitseva's work include Acute Myeloid Leukemia Research (8 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Lyubov Zaitseva is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Lyubov Zaitseva collaborates with scholars based in United Kingdom, United States and Germany. Lyubov Zaitseva's co-authors include Stuart A. Rushworth, Kristian M. Bowles, David J. MacEwan, Megan Y. Murray, Rachel E. Piddock, Christopher R. Marlein, Matthew Lawes, Manar Shafat, Niraj Shah and Dylan R. Edwards and has published in prestigious journals such as Blood, Cancer Research and Scientific Reports.

In The Last Decade

Lyubov Zaitseva

28 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lyubov Zaitseva United Kingdom 20 1.1k 598 362 343 282 28 1.7k
Sinisa Dovat United States 28 1.0k 1.0× 705 1.2× 216 0.6× 243 0.7× 366 1.3× 105 2.1k
Zhenbo Hu China 24 1.4k 1.3× 494 0.8× 220 0.6× 122 0.4× 234 0.8× 83 1.8k
Marie‐Françoise Bourgeade France 23 722 0.7× 231 0.4× 209 0.6× 116 0.3× 474 1.7× 46 1.5k
Thea Kalebic United States 21 727 0.7× 112 0.2× 238 0.7× 118 0.3× 134 0.5× 60 1.6k
Roberta Giuliani Italy 16 590 0.6× 361 0.6× 130 0.4× 114 0.3× 102 0.4× 25 1.1k
Andrea Gsur Austria 27 1.2k 1.1× 214 0.4× 262 0.7× 110 0.3× 92 0.3× 76 2.1k
ML Sherman United States 14 878 0.8× 200 0.3× 338 0.9× 74 0.2× 298 1.1× 26 1.5k
Brian P. Ashburner United States 11 876 0.8× 181 0.3× 376 1.0× 62 0.2× 272 1.0× 12 1.3k
Michael Keegan Delaney United States 14 434 0.4× 619 1.0× 80 0.2× 66 0.2× 286 1.0× 14 1.5k
Antonella Rigo Italy 21 550 0.5× 135 0.2× 195 0.5× 285 0.8× 429 1.5× 60 1.4k

Countries citing papers authored by Lyubov Zaitseva

Since Specialization
Citations

This map shows the geographic impact of Lyubov Zaitseva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lyubov Zaitseva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lyubov Zaitseva more than expected).

Fields of papers citing papers by Lyubov Zaitseva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lyubov Zaitseva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lyubov Zaitseva. The network helps show where Lyubov Zaitseva may publish in the future.

Co-authorship network of co-authors of Lyubov Zaitseva

This figure shows the co-authorship network connecting the top 25 collaborators of Lyubov Zaitseva. A scholar is included among the top collaborators of Lyubov Zaitseva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lyubov Zaitseva. Lyubov Zaitseva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zaitseva, Lyubov, et al.. (2022). Emerging molecular mechanisms and genetic targets for developing novel therapeutic strategies for treating bladder diseases. European Journal of Pharmaceutical Sciences. 173. 106167–106167. 7 indexed citations
2.
Marlein, Christopher R., Rachel E. Piddock, Lyubov Zaitseva, et al.. (2019). CD38-Driven Mitochondrial Trafficking Promotes Bioenergetic Plasticity in Multiple Myeloma. Cancer Research. 79(9). 2285–2297. 165 indexed citations
3.
Marlein, Christopher R., Lyubov Zaitseva, Rachel E. Piddock, et al.. (2018). PGC-1α driven mitochondrial biogenesis in stromal cells underpins mitochondrial trafficking to leukemic blasts. Leukemia. 32(9). 2073–2077. 21 indexed citations
4.
5.
Shafat, Manar, Thomas Oellerich, Sebastian Mohr, et al.. (2017). Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment. Blood. 129(10). 1320–1332. 252 indexed citations
6.
Piddock, Rachel E., Christopher R. Marlein, Stephen D. Robinson, et al.. (2017). PI3Kδ and PI3Kγ isoforms have distinct functions in regulating pro-tumoural signalling in the multiple myeloma microenvironment. Blood Cancer Journal. 7(3). e539–e539. 23 indexed citations
7.
Marlein, Christopher R., Lyubov Zaitseva, Rachel E. Piddock, et al.. (2017). NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts. Blood. 130(14). 1649–1660. 250 indexed citations
8.
Sun, Yu, Lyubov Zaitseva, Manar Shafat, Kristian M. Bowles, & Stuart A. Rushworth. (2016). Dual Activation of NRF2 in Multiple Myeloma and Bone Marrow Mesenchymal Stromal Cells Regulates Chemotherapy Resistance. Blood. 128(22). 3287–3287. 5 indexed citations
9.
Piddock, Rachel E., Manar Shafat, Lyubov Zaitseva, et al.. (2016). Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection. Oncotarget. 7(26). 39784–39795. 24 indexed citations
10.
Rushworth, Stuart A., Amina Abdul‐Aziz, Rachel E. Piddock, et al.. (2015). Activity of Bruton's tyrosine-kinase inhibitor ibrutinib in patients with CD117-positive acute myeloid leukaemia: a mechanistic study using patient-derived blast cells. The Lancet Haematology. 2(5). e204–e211. 20 indexed citations
11.
Abdul‐Aziz, Amina, Lyubov Zaitseva, Matthew Lawes, et al.. (2015). Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia. Scientific Reports. 5(1). 12949–12949. 29 indexed citations
12.
Shah, Niraj, Lyubov Zaitseva, Kristian M. Bowles, David J. MacEwan, & Stuart A. Rushworth. (2014). NRF2-driven miR-125B1 and miR-29B1 transcriptional regulation controls a novel anti-apoptotic miRNA regulatory network for AML survival. Cell Death and Differentiation. 22(4). 654–664. 55 indexed citations
13.
Rushworth, Stuart A., Lyubov Zaitseva, Lingling Xian, Kristian M. Bowles, & Linda Resar. (2014). High Mobility Group A1 (HMGA1) Chromatin Remodeling Protein Mediates Crosstalk Between Acute Myeloid Leukemia Blasts & the Tumor Microenvironment. Blood. 124(21). 3564–3564. 1 indexed citations
14.
Rushworth, Stuart A., Megan Y. Murray, Lyubov Zaitseva, Kristian M. Bowles, & David J. MacEwan. (2013). Identification of Bruton’s tyrosine kinase as a therapeutic target in acute myeloid leukemia. Blood. 123(8). 1229–1238. 84 indexed citations
15.
Murray, Megan Y., Stuart A. Rushworth, Lyubov Zaitseva, Kristian M. Bowles, & David J. MacEwan. (2013). Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression. Cell Cycle. 12(13). 2144–2153. 60 indexed citations
16.
Rushworth, Stuart A., Kristian M. Bowles, Lawrence N. Barrera, et al.. (2012). BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB. Cellular Signalling. 25(1). 106–112. 72 indexed citations
17.
Zaitseva, Lyubov, Stuart A. Rushworth, & David J. MacEwan. (2011). Silencing FLIPL modifies TNF-induced apoptotic protein expression. Cell Cycle. 10(7). 1067–1072. 6 indexed citations
18.
Rushworth, Stuart A., Lyubov Zaitseva, Susana Langa, Kristian M. Bowles, & David J. MacEwan. (2010). FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanism. Oncotarget. 1(5). 359–366. 31 indexed citations
19.
Zaitseva, Lyubov, Peter Cherepanov, Lada Leyens, et al.. (2009). HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome. Retrovirology. 6(1). 11–11. 80 indexed citations
20.
Zaitseva, Lyubov, Richard H. Myers, & Ariberto Fassati. (2006). tRNAs Promote Nuclear Import of HIV-1 Intracellular Reverse Transcription Complexes. PLoS Biology. 4(10). e332–e332. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sinisa Dovat Breakdown of academic impact, for papers by Zhenbo Hu Breakdown of academic impact, for papers by Marie‐Françoise Bourgeade Breakdown of academic impact, for papers by Thea Kalebic Breakdown of academic impact, for papers by Roberta Giuliani Breakdown of academic impact, for papers by Andrea Gsur Breakdown of academic impact, for papers by ML Sherman Breakdown of academic impact, for papers by Brian P. Ashburner Breakdown of academic impact, for papers by Michael Keegan Delaney Breakdown of academic impact, for papers by Antonella Rigo
Rankless by CCL
2026